Myriad Genetics Inc (NASDAQ:MYGN)

BATS BZX Real-Time Price
As of 10:39am ET
 +0.14 / +0.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 17.50, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a -33.71% decrease from the last price of 26.40.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since January, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 103.21%
Growthannually 306.48%


Growthquarterly 72.65%
Growthannually 7.25%
Key to the earnings and sales forecast charts.